Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women

Journal of Bone and Mineral Metabolism

Volumn 20, Issue 6, 2002, Pages 350-357

  Nagata Kobayashi, Shizuko ^a   Shimbo, Takuro ^a   Fukui, Tsuguya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cost effectiveness analysis; Hip fracture; Hormone replacement therapy; Osteoporosis; Screening

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; SCREENING; SENSITIVITY ANALYSIS; BONE DENSITY; COST BENEFIT ANALYSIS; ECONOMICS; FRACTURE; JAPAN; MASS SCREENING; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PROGNOSIS; RADIODENSITOMETRY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BONE DENSITY; COST-BENEFIT ANALYSIS; DENSITOMETRY, X-RAY; FEMALE; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; JAPAN; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PRACTICE GUIDELINES; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 2342587634     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740200051     Document Type: Article

References (33)

1. Statistics Bureau (2001) Japan statistical yearbook. 2002. Ministry of Public Management, Home Affairs, Posts, and Telecommunications, Tokyo
2. Fujiwara S (1995) Estimating incidence of osteoporosis by bone mineral density, from population based study (in Japanese). Tyouju Kagaku Kenkyuu Kenkyuuhoukoku (Report of Aging and Health Research) 4:508-511
3. Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746
4. Tosteson AN, Rosenthal DI, Melton LJ 3rd, Weinstein MC (1990) Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med 113:594-603
5. Clark AP, Schuttinga JA (1992) Targeted estrogen/progesterone replacement therapy for osteoporosis: calculation of health care cost savings. Osteoporos Int 2:195-200
6. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13:322-338
7. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
8. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254-1259
9. Orimo H, Hashimoto T, Sakata K, Yoshimura N, Suzuki T (2000) Trends in the incidence of hip fracture in Japan, 1987-1997: the third nationwide survey. J Bone Miner Metab 18:126-131
10. Kitamura S, Hasegawa Y, Suzuki S, Sasaki R, Iwata H, Wingstrand H, Thorngren KG (1998) Functional outcome after hip fracture in Japan. Clin Orthop 348:29-36
11. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
12. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195-1198
13. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ (2000) A prospective, observational study of post-menopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133:933-941
14. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
15. Barrett-Connor E, Stuenkel CA (2001) Hormone replacement therapy (HRT) - risks and benefits. Int J Epidemiol 30:423-426
16. Finkler SA (1982) The distinction between cost and charges. Ann Intern Med 96:102-109
17. Division of Medicine, Department of Insurance, Japanese Ministry of Health and Welfare (2000) Interpretation of the Social Insurance Reimbursement Table (in Japanese). Research Institute of Social Insurance, Tokyo
18. Ogawa K, Fujino S (1996) Estimates of cost-of-illness of osteoporosis in Japan in 1992 (in Japanese). J Health Care and Society 6:1-15
19. Working group for establishing the guideline for the treatment of osteoporosis (1998) Guideline for the treatment (pharmacological intervention) (in Japanese). Osteoporosis Jpn 6:205-253
20. Drummond MF, O'Brien B, Stoddart GL, George WT (1997) Methods for the Economic Evaluation of Health Care Programmes. 2nd edn. Oxford University Press, New York, pp 15-17
21. Salkeld G, Cameron ID, Cumming RG, Easter S, Seymour J, Kurrle SE, Quine S (2000) Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ 320:341-346
22. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276:1253-1258
23. Gold MR, Siegel JE, Russel LB, Weinstein MC (1996) Cost-effectiveness in Health and Medicine. Oxford University Press, New York, pp 230-233
24. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR (1995) Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 122:9-16
25. Recker RR, Davies KM, Dowd RM, Heaney RP (1999) The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Ann Intern Med 130:897-904
26. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077-2082
27. Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research. J Bone Miner Metab 19:331-337
28. National Cholesterol Education Program (1994) Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1333-1445
29. Tsuji I, Fukao A, Sugawara N, Shoji T, Kuwajima I, Hisamichi S (1991) Cost-effectiveness analysis of screening for gastric cancer in Japan. Tohoku J Exp Med 164:279-284
30. Shimbo T, Glick HA, Eisenberg JM (1994) Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int J Technol Assess Health Care 10:359-375
31. Okubo I, Glick H, Frumkin H, Eisenberg JM (1991) Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer 67:2021-2029
32. Sato S, Matunaga G, Tsuji I, Yajima A, Sasaki H (1999) Determining the cost-effectiveness of mass screening for cervical cancer using common analytic models. Acta Cytol 43:1006-1014
33. Parker MJ, Gillespie LD, Gillespie WJ (2001) Hip protectors for preventing hip fractures in the elderly (Cochrane Review). Cochrane Database Syst Rev 2:CD001255